ResultsIQ

ResultsIQ › Latest results › Mangalam Organics Limited

Mangalam Organics Limited Q1 FY26 results deck summary

NSE: MANORG · BSE: 514418

Results deck of 9 Aug 2025, summarised by AI from the filing.

Q1 FY26 revenue ₹146.55 cr (+24.2%) and PAT ₹12.23 cr (+632.30%), with lower input costs lifting profitability.

Key takeaways

  1. Q1 FY26 revenue Revenue ₹146.55 cr (Q1 FY25: ₹117.99 cr, +24.2%), with PAT ₹12.23 cr (Q1 FY25: ₹1.67 cr, +632.30%).
  2. Input costs Decrease in various input costs led to increase in profitability for the quarter end.
  3. Intermediates Endeavour to unlock saleable value of intermediates and improve quality of Terpineol is on track.

Original filing on BSE

Mangalam Organics Limited Q1 FY27 results

As filed: Revenue ₹179 cr (+22% year on year), EBITDA ₹22.2 cr (+1% year on year), PAT ₹7.3 cr (−39% year on year), EBITDA margin 12.4% (−257 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹154 cr (+2% year on year), EBITDA ₹46.6 cr (+122% year on year), PAT ₹6.0 cr (+20% year on year), EBITDA margin 30.4% (+1,000 bps). Score 60 of 100, In line with trend. Revenue growth was below the company's own trend; EBITDA growth was well above it; profit growth was well below it. EBITDA margin rose 1000 bps year on year. Profit lagged EBITDA because of depreciation, interest or other income, not the business. Revenue fell 7% from last quarter. Share price after the results: −4.4% in 27 days (Nifty 500: +2.0%).
  • Q3 FY26: Revenue ₹164 cr (+33% year on year), EBITDA ₹19.3 cr (+21% year on year), PAT ₹4.3 cr (+8% year on year), EBITDA margin 11.8% (−116 bps). Score 58 of 100, In line with trend. Revenue growth was well above the company's own trend; EBITDA growth was in line with it; profit growth was well below it. EBITDA margin fell 116 bps year on year. Consolidated profit +8% but standalone -63%. Revenue grew on the previous quarter, against its usual seasonal pattern. Revenue rose ₹40.3 cr on a year ago, more than the ₹13.0 cr it added the year before. Share price after the results: −2.3% in 29 days (Nifty 500: −9.6%).
  • Q2 FY26: Revenue ₹158 cr (+14% year on year), EBITDA ₹0.0 cr (−100% year on year), PAT ₹3.0 cr (+167% year on year), EBITDA margin 0.0% (−870 bps). Score 35 of 100, Below trend. Revenue growth was above the company's own trend; EBITDA growth was well below it; profit before exceptional items growth was in line with it. EBITDA margin fell 870 bps year on year. Other income 525% of PBT. Profit fell 47% from last quarter. Profit before exceptional items rose ₹5.0 cr on a year ago, more than the ₹2.0 cr it added the year before. Share price after the results: −10.6% in 28 days (Nifty 500: −0.5%).
  • Q1 FY26: Revenue ₹147 cr (+25% year on year), EBITDA ₹22.0 cr (+100% year on year), PAT ₹12.0 cr (+300% year on year), EBITDA margin 15.0% (+564 bps). Score 69 of 100, Above trend. Revenue growth was above the company's own trend; EBITDA and profit growth were well above it. EBITDA margin rose 564 bps year on year. Other income 27% of PBT. Tax rate 13%. Share price after the results: +27.3% in 28 days (Nifty 500: +1.7%).
  • Q4 FY25: Revenue ₹150 cr (+43% year on year), EBITDA ₹21.0 cr (+91% year on year), PAT ₹5.0 cr (+150% year on year), EBITDA margin 14.0% (+352 bps). Score 92 of 100, Above trend. Revenue and EBITDA growth were well above the company's own trend. EBITDA margin rose 352 bps year on year. Tax rate 14%. Consolidated profit +150% but standalone -33%. Revenue grew on the previous quarter, against its usual seasonal pattern. Share price after the results: +54.0% in 30 days (Nifty 500: +7.6%).
  • Q3 FY25: Revenue ₹124 cr (+12% year on year), EBITDA ₹16.0 cr (+60% year on year), PAT ₹4.0 cr (+300% year on year), EBITDA margin 12.9% (+389 bps). Score 84 of 100, Above trend. Revenue growth was above the company's own trend; EBITDA growth was well above it. EBITDA margin rose 389 bps year on year. Revenue fell 10% from last quarter.
  • Q2 FY25: Revenue ₹138 cr (−18% year on year), EBITDA ₹12.0 cr (+20% year on year), PAT ₹2.0 cr (+100% year on year), EBITDA margin 8.7% (+278 bps). Score 55 of 100, In line with trend. EBITDA margin rose 278 bps year on year. Not enough history for a trend yet: scored on growth alone.

Past price moves after results do not indicate future moves. Not a recommendation.

Mangalam Organics Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.